Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spire Healthcare GroupLSE:SPI -0.45%73 5-Year Yield-on-Cost % is 0.66 as of Jul. 23, 2026, which is 47% below its 10-year median of 1.25. GuruFocus rates LSE:SPI with a GF Score™ of 73/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Spire Healthcare Group ranks worse than 85.56% on this metric.
Spire Healthcare Group's yield on cost for the quarter that ended in Dec. 2025 was 0.66.
The historical rank and industry rank for Spire Healthcare Group's 5-Year Yield-on-Cost % or its related term are showing as below:
LSE:SPI'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.19 Med: 1.25 Max: 7.22
Current: 0.66
During the past 13 years, Spire Healthcare Group's highest Yield on Cost was 7.22. The lowest was 0.19. And the median was 1.25.
LSE:SPI's 5-Year Yield-on-Cost % is ranked worse than 85.56% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs LSE:SPI: 0.66
Spire Healthcare Group (LSE:SPI) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Spire Healthcare Group 5-Year Yield-on-Cost % Related Terms
LSE:SPI vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Spire Healthcare Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's 5-Year Yield-on-Cost % falls into.
Spire Healthcare Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Spire Healthcare Group (LSE:SPI) has a 5-Year Yield-on-Cost % of 0.66 as of Jul. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Spire Healthcare Group and its competitors. This is 47% below median its historical median of 1.25. Over the past decade, Spire Healthcare Group's 5-Year Yield-on-Cost % has ranged from 0.19 to 7.22. According to the industry distribution chart, Spire Healthcare Group ranks #237 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 85.6%.
Is Spire Healthcare Group's 5-Year Yield-on-Cost % too high?
Spire Healthcare Group's current 5-Year Yield-on-Cost % of 0.66 is 47% below median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 7.22. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Spire Healthcare Group's value of 0.66 is 77.2% below this industry median. Based on the distribution chart, Spire Healthcare Group ranks #237 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Spire Healthcare Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #237 out of 277 companies for 5-Year Yield-on-Cost %. This places Spire Healthcare Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. Spire Healthcare Group's value of 0.66 is 77.2% below this benchmark. Historically, Spire Healthcare Group's own 5-Year Yield-on-Cost % has ranged from 0.19 to 7.22 over the past decade. While the company's 10-year median is 1.25 vs. the industry median of 2.90, Spire Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current 5-Year Yield-on-Cost % of 0.66 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current 5-Year Yield-on-Cost % is 0.66, which is 47% below median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (LSE:SPI) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.21 — trading 18.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.66, which is 47% below median its 10-year median of 1.25 and 77.2% below the Healthcare Providers & Services industry median of 2.90. Spire Healthcare Group's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Spire Healthcare Group (LSE:SPI), the current 5-Year Yield-on-Cost % is 0.66 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (LSE:SPI) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.21 is trading 18.5% below its estimated GF Value™ of £2.71.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for LSE:SPI:
5-Year Yield-on-Cost %: 0.66 (47% below median its 10-year median of 1.25)
GF Value™: £2.71 vs. price of £2.21 (18.5% below fair value)
Industry Position: 77.2% below the Healthcare Providers & Services median (#237 of 277)
No single metric tells the full story. See the LSE:SPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
73GF Score
Get the complete analysis for LSE:SPI
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SPI has been successfully added to your 
